H-Index
85
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
12%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
AmJCaseRep

Annals
ISI-Home

eISSN: 1643-3750

Get your full text copy in PDF

T Cell Profile was Altered in Pulmonary Tuberculosis Patients with Type 2 Diabetes

Xianhua Wang, Aiguo Ma, Xiuxia Han, Lei Chan, Hui Liang, Aishan Litifu, Feng Xue

(The Institute of Human Nutrition, Medical College of Qingdao University, Qingdao, Shandong, China (mainland))

Med Sci Monit 2018; 24: CLR636-642

DOI: 10.12659/MSM.905651


BACKGROUND: Studies have suggested that type 2 diabetes (T2D) increases the risk of active pulmonary tuberculosis (TB) infection. T2D might exacerbate TB severity and adversely impact the treatment of TB patients by suppressing the immune response of TB. However, how the immune cell profiles are changed in Chinese TB patients with coincident of T2D compared with TB patients without T2D is still unclear.
MATERIAL AND METHODS: To explore the immune cell profile alteration in TB patients with T2D, we collected blood samples from 46 TB patients with or without T2D and measured the profiles of T cell subsets.
RESULTS: We found TB patients with coincident of T2D had higher percentages of Th2 and Th17 cells after TB antigens stimulation, while they had unchanged Th1 cells and decreased CD8+ cytotoxic T cells compared to TB patients without T2D. However, no significant difference in baseline percentages of these T cells subsets was observed.
CONCLUSIONS: T2D has important impacts on regulating anti-TB immunity by increasing Th2 and Th17 cell differentiation, but reducing the activity of CD8+ T cells. Our study supports the need to perform longitudinal studies to evaluate the roles of immunological interaction between T2D and TB in TB development.

Keywords: Diabetes Mellitus, Type 2, Immunity, Active, Mycobacterium tuberculosis, Receptors, Antigen, T-Cell, Receptors, Cytokine

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree